Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Parkinson's Disease

Free Subscription Articles published in Exp Neurol Retrieve available abstracts of 58 articles: HTML format

Single Articles

March 2008
1. PAPA SM
   The cannabinoid system in Parkinson's disease: Multiple targets to motor effects.
   Exp Neurol. 2008;.
   PubMed     Related articles   
   
   
   
2. WOODLEE MT , Kane JR, Chang J, Cormack LK, et al
   Enhanced function in the good forelimb of hemi-parkinson rats: Compensatory adaptation for contralateral postural instability?
   Exp Neurol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. TEMEL Y
   Subthalamic nucleus stimulation in Parkinson's disease: The other side of the medallion.
   Exp Neurol. 2008;.
   PubMed     Related articles   
   
   
   February 2008
4. TABBAL SD , Ushe M, Mink JW, Revilla FJ, et al
   Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in parkinson disease.
   Exp Neurol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. BJUGSTAD KB , Teng YD, Redmond DE Jr, Elsworth JD, et al
   Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.
   Exp Neurol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
6. ANDROULIDAKIS AG , Mazzone P, Litvak V, Penny W, et al
   Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease.
   Exp Neurol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. GOETZE O , Woitalla D
   The role of MPTP in Parkinson's disease: Connecting brain and gut?
   Exp Neurol. 2008;.
   PubMed     Related articles   
   
   
   
8. KIRIK D , Gai WP, Jensen PH
   Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration?
   Exp Neurol. 2008;209:3-4.
   PubMed     Related articles   
   
   
   December 2007
9. CHATURVEDI RK , Shukla S, Seth K, Agrawal AK, et al
   Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.
   Exp Neurol. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. MAJSAK MJ , Kaminski T, Gentile AM, Gordon AM, et al
    Effects of a moving target versus a temporal constraint on reach and grasp in patients with Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
11. HERSHEY T , Wu J, Weaver PM, Perantie DC, et al
    Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
12. MCCOY MK , Martinez TN, Ruhn KA, Wrage PC, et al
    Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. ALVAREZ-FISCHER D , Henze C, Strenzke C, Westrich J, et al
    Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
14. HARNACK D , Meissner W, Jira JA, Winter C, et al
    Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. MAGUIRE-ZEISS KA , Mhyre TR, Federoff HJ
    Gazing into the future: Parkinson's disease gene therapeutics to modify natural history.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. EBERT AD , Beres AJ, Barber AE, Svendsen CN, et al
    Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
17. ULUSOY A , Bjorklund T, Hermening S, Kirik D, et al
    In vivo gene delivery for development of mammalian models for Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
18. EUSEBIO A , Chen CC, Lu CS, Lee ST, et al
    Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. FISKE BK , Frasier MA, Sherer TB
    Special focus section: Gene therapy for Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles   
    
    
    
20. LINDVALL O , Wahlberg LU
    Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. CRESS DE
    The need for regulatable vectors for gene therapy for Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
22. LEWIS TB , Standaert DG
    Commentary: Design of clinical trials of gene therapy in Parkinson disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. MANDEL RJ , Burger C, Snyder RO
    Viral vectors for in vivo gene transfer in Parkinson's disease: Properties and clinical grade production.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. FIANDACA M , Forsayeth J, Bankiewicz K
    Current status of gene therapy trials for Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. HAVERT MB
    A regulatory perspective on the development of gene therapy for Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles   
    
    
    
26. CHESSELET MF
    In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. ROJO AI , Cavada C, de Sagarra MR, Cuadrado A, et al
    Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. MORGESE MG , Cassano T, Cuomo V, Giuffrida A, et al
    Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
29. KORDOWER JH , Olanow CW
    Regulatable promoters and gene therapy for Parkinson's disease: Is the only thing to fear, fear itself?
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. PORRAS G , Bezard E
    Preclinical development of gene therapy for Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
31. WRIGHT WG , Gurfinkel VS, Nutt J, Horak FB, et al
    Axial hypertonicity in Parkinson's disease: Direct measurements of trunk and hip torque.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
32. HALLIDAY GM , McCann H
    Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. TANSEY MG , McCoy MK, Frank-Cannon TC
    Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. MANFREDSSON FP , Burger C, Sullivan LF, Muzyczka N, et al
    rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
35. YASUDA T , Fukuda-Tani M, Nihira T, Wada K, et al
    Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. ANDERSON G , Noorian AR, Taylor G, Anitha M, et al
    Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. ASANUMA M , Miyazaki I
    Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?
    Exp Neurol. 2007;.
    PubMed     Related articles   
    
    
    April 2007
38. AZIZ T
    Commentary to "Excessive synchronisation of basal ganglia neurons at 20 Hz slows movement in Parkinson's disease"
    Exp Neurol. 2007;.
    PubMed     Related articles   
    
    
    March 2007
39. MILLER RM , Kiser GL, Kaysser-Kranich T, Casaceli C, et al
    Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Exp Neurol. 2007;204:421-32.
    PubMed     Related articles    Abstract available
    
    
    February 2007
40. ESPOSITO E , Di Matteo V, Benigno A, Pierucci M, et al
    Non-steroidal anti-inflammatory drugs in Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. LIEBETANZ D , Baier PC, Paulus W, Meuer K, et al
    A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. TROTTENBERG T , Kupsch A, Schneider GH, Brown P, et al
    Frequency-dependent distribution of local field potential activity within the subthalamic nucleus in Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. CHEN CC , Litvak V, Gilbertson T, Kuhn A, et al
    Excessive synchronization of basal ganglia neurons at 20 Hz slows movement in Parkinson's disease.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. COX H , Togasaki DM, Chen L, Langston JW, et al
    The selective kappa-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.
    Exp Neurol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
45. LUO Y , Henricksen LA, Giuliano RE, Prifti L, et al
    VIP is a transcriptional target of Nurr1 in dopaminergic cells.
    Exp Neurol. 2007;203:221-32.
    PubMed     Related articles    Abstract available
    
    
    December 2006
46. LI QX , Mok SS, Laughton KM, McLean CA, et al
    Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
47. ZEEVALK GD , Manzino L, Sonsalla PK, Bernard LP, et al
    Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
48. SCHELLER D , Chan P, Li Q, Wu T, et al
    Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
49. LIANG CL , Wang TT, Luby-Phelps K, German DC, et al
    Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
50. OBESO JA , Rodriguez-Oroz MC, Javier Blesa F, Guridi J, et al
    The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
    Exp Neurol. 2006;.
    PubMed     Related articles   
    
    
    
51. PREDIGER RD , Batista LC, Medeiros R, Pandolfo P, et al
    The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
52. POGOSYAN A , Kuhn AA, Trottenberg T, Schneider GH, et al
    Elevations in local gamma activity are accompanied by changes in the firing rate and information coding capacity of neurons in the region of the subthalamic nucleus in Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
53. BRUNDIN P , Angela Cenci M, Wieloch T
    On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
    Exp Neurol. 2006;.
    PubMed     Related articles   
    
    
    
54. HASBANI DM , O'malley KL
    Wld(S) mice are protected against the Parkinsonian mimetic MPTP.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
55. LUQUIN MR , Saldise L, Guillen J, Belzunegui S, et al
    Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
56. MCKAY BS , Goodman B, Falk T, Sherman SJ, et al
    Retinal pigment epithelial cell transplantation could provide trophic support in Parkinson's disease: Results from an in vitro model system.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
57. VOGT IR , Lees AJ, Evert BO, Klockgether T, et al
    Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
58. YAZDANI U , German DC, Liang CL, Manzino L, et al
    Rat model of Parkinson's disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP(+)).
    Exp Neurol. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: